Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Molecular Imaging and Biology
|
September 16, 2018
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [
Yafu Yin, Scott P Campbell, Mark C Markowski, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
Karen S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
European Urology
|
January 19, 2019
The Microbiome and Genitourinary Cancer: A Collaborative Review
Mark C Markowski, Stephen A Boorjian, Jeremy P Burton, et al.
The Oncologist
|
June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations
Mark C Markowski, Cora N Sternberg, Hao Wang, et al.
The Journal of Urology
|
April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer
Mark C Markowski, Ramy Sedhom, Wei Fu, et al.
The Prostate
|
June 1, 2018
Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate
Mark C Markowski, Gretchen K Hubbard, Jessica L Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2022
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent
Mark C Markowski, Ronald Tutrone, Christopher Pieczonka, et al.
Annals of Nuclear Medicine
|
June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CT
Alexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
Urology
|
April 17, 2021
Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes
Shagnik Ray, Joseph G Cheaib, Michael J Biles, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Molecular Imaging and Biology
|
September 16, 2018
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [
Yafu Yin, Scott P Campbell, Mark C Markowski, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
Karen S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
European Urology
|
January 19, 2019
The Microbiome and Genitourinary Cancer: A Collaborative Review
Mark C Markowski, Stephen A Boorjian, Jeremy P Burton, et al.
The Oncologist
|
June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations
Mark C Markowski, Cora N Sternberg, Hao Wang, et al.
The Journal of Urology
|
April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer
Mark C Markowski, Ramy Sedhom, Wei Fu, et al.
The Prostate
|
June 1, 2018
Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate
Mark C Markowski, Gretchen K Hubbard, Jessica L Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2022
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent
Mark C Markowski, Ronald Tutrone, Christopher Pieczonka, et al.
Annals of Nuclear Medicine
|
June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CT
Alexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
Urology
|
April 17, 2021
Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes
Shagnik Ray, Joseph G Cheaib, Michael J Biles, et al.
Page
of 8